These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10787075)

  • 21. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
    Zhang GQ; Ge L; Ding W; Li HJ
    Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients.
    Xia F; Wu LL; Lau WY; Huan HB; Wen XD; Ma KS; Li XW; Bie P
    World J Gastroenterol; 2016 Jun; 22(23):5384-92. PubMed ID: 27340354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Miyazaki I
    Hepatogastroenterology; 1996; 43(12):1415-20. PubMed ID: 8975941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta-analysis.
    Moran A; Ramos LF; Picado O; Pendola F; Sleeman D; Dudeja V; Merchant N; Yakoub D
    J Surg Oncol; 2019 Mar; 119(4):455-463. PubMed ID: 30575028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative adjuvant chemotherapy after radical hepatic resection for hepatocellular carcinoma (HCC).
    Kohno H; Nagasue N; Hayashi T; Yamanoi A; Uchida M; Ono T; Yukaya H; Kimura N; Nakamura T
    Hepatogastroenterology; 1996; 43(12):1405-9. PubMed ID: 8975939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of chemoembolization as an adjuvant therapy for primary liver carcinoma after surgical resection].
    Li JQ; Zhang YQ; Zhang WZ
    Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):387-9. PubMed ID: 7895595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.
    Lei J; Zhong J; Hao J; Liu Z; Zhang P; Wu L; Yan L; Zhu J; Zeng Y; Li B; Wen T; Wang W
    Oncotarget; 2016 Jul; 7(27):42598-42607. PubMed ID: 26981887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
    Zuo CH; Xia M; Liu JS; Qiu XX; Lei X; Xu RC; Liu HC; Li JL; Li YG; Li QL; Xiao H; Hong Y; Wang XH; Zhu HZ; Wu QF; Burns M; Liu C
    Asian Pac J Cancer Prev; 2015; 16(1):245-51. PubMed ID: 25640360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of adjuvant individualized chemotherapy for hepatocellular carcinoma after liver transplantation].
    Chen GH; Lu MQ; Cai CJ; Yang Y; He XS; Zhu XF
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1040-3. PubMed ID: 15498315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
    Murakami T; Ishimaru H; Sakamoto I; Uetani M; Matsuoka Y; Daikoku M; Honda S; Koshiishi T; Fujimoto T
    Cardiovasc Intervent Radiol; 2007; 30(4):696-704. PubMed ID: 17497071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy.
    Saab S; McTigue M; Finn RS; Busuttil RW
    Exp Clin Transplant; 2010 Dec; 8(4):307-13. PubMed ID: 21143097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis.
    Ueno S; Tanabe G; Yoshida A; Yoshidome S; Takao S; Aikou T
    Cancer; 1999 Jul; 86(2):248-54. PubMed ID: 10421260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of postoperative adjuvant arterial infusion chemotherapy in resected hepatoma patients].
    Nakashima K; Aramaki M; Yoshida T; Kim YI; Kitano S; Kobayashi M; Suzuki K; Aikawa H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1481-4. PubMed ID: 8396901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin-C].
    Hwang JY; Jang BK; Kwon KM; Chung WJ; Park KS; Cho KB; Hwang JS; Ahn SH; Kim GC; Kim YH; Choi JS; Kwon JH
    Korean J Gastroenterol; 2005 Feb; 45(2):118-24. PubMed ID: 15725716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
    Lau WY; Lai EC; Leung TW; Yu SC
    Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma.
    Söderdahl G; Bäckman L; Isoniemi H; Cahlin C; Höckerstedt K; Broomé U; Mäkisalo H; Friman S; Ericzon BG
    Transpl Int; 2006 Apr; 19(4):288-94. PubMed ID: 16573544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.
    Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
    Int J Oncol; 2013 Jan; 42(1):151-60. PubMed ID: 23174998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.